BioCentury
ARTICLE | Company News

Argonex and Wyeth-Lederle in Chlamydia deal

February 3, 2000 8:00 AM UTC

Argonex (Charlottesville, Va.) and Wyeth-Lederle Vaccines will indentify antigens associated with Chlamydia pneumoniae for the development of vaccines. Argonex will identify peptides expressed on Chla...